Clindamycin Injection USP in 5% Dextrose, 900 mg per 50 mL (12 mg/mL) in GALAXY 50 mL Sin…
Official notice from a government agency or its published feed.
Reason: CGMP Deviations
Class IIA mid-level FDA recall: the product may cause temporary or reversible health problems. · Ongoing · US Nationwide; Puerto Rico; and Chile.
Hazard: CGMP Deviations
View the FDA enforcement report ↗ ← All reports